Literature DB >> 1554202

Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes.

J M Grigg1, A Barber, M Silverman.   

Abstract

This study investigated the effect of prolonged rupture of the amniotic membranes (PROM) and probable maternal or fetal sepsis without PROM on the newborn preterm airway. Bronchoalveolar lavage fluid (BALF) was obtained from 38 infants in the first day of life and analyzed for number of white cells and concentration of interleukin-6 (IL-6). The volume of lung epithelial lining fluid (ELF) was estimated using the urea dilution technique. Infants with PROM (n = 13) and those with sepsis (n = 8) had higher total numbers of white cells in BALF compared with infants without PROM or sepsis (n = 17) (55 and 44 versus 7 x 10(4) white cells, p less than 0.01). Uncorrected and urea-corrected IL-6 concentrations were also higher in the two groups (18.5 and 30.8 versus 5.0 fmol/ml BALF, p less than 0.01; 157.7 and 444 versus 88.5 fmol/ml ELF, p less than 0.05). There was a significant correlation between BALF white cells and uncorrected IL-6 concentrations (rs = 0.78, p less than 0.0001). Detectable serum C-reactive protein in newborn infants was associated with increased levels of IL-6 in BALF (42.2 versus 11.8 fmol/ml BALF, p less than 0.05). We conclude that PROM is associated with airway inflammation and raised levels of IL-6 in neonatal lung fluid within the first 24 h of life and that this may initiate a systemic stress response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554202     DOI: 10.1164/ajrccm/145.4_Pt_1.782

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

1.  Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth.

Authors:  P Groneck; B Goetze-Speer; C P Speer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

2.  Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors:  K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

3.  Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants.

Authors:  B Jónsson; K Tullus; A Brauner; Y Lu; G Noack
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

4.  Inflammatory mediators and bronchopulmonary dysplasia.

Authors:  P Groneck; C P Speer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

5.  Bronchoalveolar lavage fluid glutathione in intubated premature infants.

Authors:  J Grigg; A Barber; M Silverman
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

6.  Pulmonary inflammatory cells in ventilated preterm infants: effect of surfactant treatment.

Authors:  S Arnon; J Grigg; M Silverman
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

Review 7.  Chronic lung disease of prematurity: are we too cautious with steroids?

Authors:  M Silverman
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

8.  Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines.

Authors:  S Koyama; E Sato; H Nomura; K Kubo; M Miura; T Yamashita; S Nagai; T Izumi
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products.

Authors:  B Crestani; P Cornillet; M Dehoux; C Rolland; M Guenounou; M Aubier
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  Inflammatory cells in the lungs of premature infants on the first day of life: perinatal risk factors and origin of cells.

Authors:  J Grigg; S Arnon; A Chase; M Silverman
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.